Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
BTC/USD Is Down 43% From Its All-Time High as Investors Explore AI Trading Bots Like AIX Alpha
-
Triller Group Inc. Receives Nasdaq Exception To Regain Minimum Bid Price Compliance
-
Lexitas Appoints Joe Giannetti as Chief Information Officer and Chief Information Security Officer
-
Abell Pest Control Encourages Canadians to Be Aware of Urban Wildlife
-
Kanary Launches Human Attack Surface Management for X and LinkedIn
-
Tessa Dairy Machinery Launches 3A Certified Commercial Cream Separator Line for U.S. Dairy Producers
-
U.S. District Court Issues Decision Regarding CINVANTI® Patents
-
Gaxos Secures Additional Funding from Amazon AWS to Accelerate AI Sales Platform Development
-
Alamar Biosciences Makes Home-Collected Fingerstick Samples Compatible with Ultra High-Sensitivity, Multiplex Proteomics
-
Trident Digital Tech Holdings Launches TDTHAI Across Asia-Pacific to Accelerate Enterprise AI Deployment and Digital Infrastructure Growth
-
SCIENTURE Receives U.S. Patent Covering REZENOPY™ (Naloxone HCl) Nasal Spray 10 mg, Strengthening Intellectual Property Protection Through 2041
-
Candel Therapeutics Announces Publication in The Lancet Oncology of Pivotal Phase 3 Data Demonstrating Significant Improvement in Disease-Free Survival with Aglatimagene Besadenovec (CAN-2409) in Loca
-
Hydrafacial Introduces HydraScalp® with Keravive™ as Next Evolution in Scalp Health
-
Lakeland Capital Welcomes 2026 Summer Interns
-
Fluent Inc. Subsidiary Trevant Launches as Creator Marketing Agency Built on Performance Discipline
-
4media group Acquires The CauseWay Agency, Expanding Government, Nonprofit and Public Affairs Expertise
-
Scality and Biomemory partner to pioneer ultra-secure, DNA-based data archives with 150-year retention
-
Bryan and Sarah Baeumler to Host Home Town Takeover Canada, Produce New Originals, with HGTV in Canada as Exclusive Home
-
ORYZON Initiates Patient Enrollment in IDEAL Phase II Trial of Iadademstat in Essential Thrombocythemia
-
Taiwan Excellence Unveils Edge AI and AV-over-IP Ecosystem at InfoComm 2026
-
Adam L. Metz Named President and Chief Executive Officer at Orrstown Bank
-
Phoenix Mobile Home Announces Direct Cash Buying Services for Mobile Homes in Any Condition Across Phoenix
-
Maxus Mining Announces Receipt of DTC Eligibility
-
AYR Wellness Announces Closing of Florida, New Jersey and Nevada Operations Transfer to Arboretum
-
We Buy Mobile Homes Phoenix Offers Arizona Sellers 24-Hour Cash Offers With No Repairs or Commissions
-
Cartier Cuts 2.1 g/t Au Over 19.1 m at Main Sector (Cadillac); Confirming Multiple Parallel Gold Zones Near Surface
-
MAX Power Takes Natural Hydrogen Commercialization Vision to Washington, DC
-
RTI Appoints Defense Technology Leader Dr. Julia Filiberti Allen to Advisory Board to Accelerate A&D Growth
-
Skyhawk Security Earns Two Cloud Security Awards for Advancing Autonomous AI Threat Defense
-
American Fusion Inc. (OTC: AMFN) Expands Intellectual Property Portfolio with Patent Application Covering Future Commercial Texatron™ Fusion Engine™ Systems
-
Stansberry Asset Management Named to Inc.’s 2026 Best Workplaces List
-
Veriff Named a Leader in G2's Summer 2026 Identity Verification Grid® Report
-
electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub
-
SpyGlass Pharma Appoints Mike Pinder as Vice President, Marketing
-
Metro Detroit Homebuyers Get a Rare “Choice Without a Crash” Window, New Lucido Real Estate Analysis Finds
-
Troy A. Rafferty of Rafferty Domnick Cunningham & Yaffa to Present Advanced Trial Skills Seminar at the 2026 Florida Justice Association Annual Convention
-
ProKidney Appoints Kenneth Locke as Chief Technical Officer
-
Centrical Raises $39M to Transform Frontline Performance for the AI Era Workforce
-
LVN Real Estate Offers Denver Homeowners Cash Home-Buying Services With No Commissions or Repairs
-
Lantheus' LNTH-2513 (18F-GP1) PET/CT Awarded SNMMI’s Image of the Year
-
INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer's Trial
-
Realize Medical Appoints Canadian Technology Leader Andrew Waitman to Board of Directors
-
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd.
-
Village Super Market, Inc. Reports Results for the Third Quarter Ended April 25, 2026
-
Cingulate Receives Complete Response Letter from FDA for CTx-1301
-
Twelve Legs Marketing Celebrates 10 Years of Strategic Digital Marketing and Video Services Growth, Award-Winning Work, and Long-Term Partnerships
-
GraniteShares Announces Monthly Distributions for its Autocallable ETFs: ANV, TLA, MSR, ATC, PLA, AHD, SCA and MRA
-
FLYTE ACTIVATES HIGH-FREQUENCY BELMONT STAKES FLIGHT PROGRAM, DEPLOYING FLEET TO CAPTURE TRIPLE CROWN DEMAND
-
Cosmos Health Provides Balance Sheet Update: Highlights European Investment Bank Financing Discussions for up to €25M, Eliminates 38% of Warrant Overhang with No Dilution; Reaffirms Growth Trajector
-
VCI Global’s V Gallant Signs Definitive Agreement to Acquire Rights Platform Covering 241,000 Hectares of Indonesian Forestry Assets to Accelerate AI, Carbon Credit and RWA Ecosystem Strategy
